BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37475856)

  • 1. B cell abnormalities and autoantibody production in patients with partial RAG deficiency.
    Min Q; Csomos K; Li Y; Dong L; Hu Z; Meng X; Yu M; Walter JE; Wang JY
    Front Immunol; 2023; 14():1155380. PubMed ID: 37475856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency.
    Delmonte OM; Villa A; Notarangelo LD
    Blood; 2020 Feb; 135(9):610-619. PubMed ID: 31942628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
    IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying
    Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V
    Front Immunol; 2023; 14():1268620. PubMed ID: 38022635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human RAG mutations: biochemistry and clinical implications.
    Notarangelo LD; Kim MS; Walter JE; Lee YN
    Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
    Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
    J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in understanding RAG deficiencies.
    Gennery A
    F1000Res; 2019; 8():. PubMed ID: 30800289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.
    Walter JE; Rosen LB; Csomos K; Rosenberg JM; Mathew D; Keszei M; Ujhazi B; Chen K; Lee YN; Tirosh I; Dobbs K; Al-Herz W; Cowan MJ; Puck J; Bleesing JJ; Grimley MS; Malech H; De Ravin SS; Gennery AR; Abraham RS; Joshi AY; Boyce TG; Butte MJ; Nadeau KC; Balboni I; Sullivan KE; Akhter J; Adeli M; El-Feky RA; El-Ghoneimy DH; Dbaibo G; Wakim R; Azzari C; Palma P; Cancrini C; Capuder K; Condino-Neto A; Costa-Carvalho BT; Oliveira JB; Roifman C; Buchbinder D; Kumanovics A; Franco JL; Niehues T; Schuetz C; Kuijpers T; Yee C; Chou J; Masaad MJ; Geha R; Uzel G; Gelman R; Holland SM; Recher M; Utz PJ; Browne SK; Notarangelo LD
    J Clin Invest; 2015 Nov; 125(11):4135-48. PubMed ID: 26457731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency.
    Geier CB; Farmer JR; Foldvari Z; Ujhazi B; Steininger J; Sleasman JW; Parikh S; Dilley MA; Pai SY; Henderson L; Hazen M; Neven B; Moshous D; Sharapova SO; Mihailova S; Yankova P; Naumova E; Özen S; Byram K; Fernandez J; Wolf HM; Eibl MM; Notarangelo LD; Calabrese LH; Walter JE
    Front Immunol; 2020; 11():574738. PubMed ID: 33193364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAG Deficiency: Two Genes, Many Diseases.
    Delmonte OM; Schuetz C; Notarangelo LD
    J Clin Immunol; 2018 Aug; 38(6):646-655. PubMed ID: 30046960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mutations and recombination activity in RAG-deficient patients.
    Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
    Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients.
    Cifaldi C; Rivalta B; Amodio D; Mattia A; Pacillo L; Di Cesare S; Chiriaco M; Ursu GM; Cotugno N; Giancotta C; Manno EC; Santilli V; Zangari P; Federica G; Palumbo G; Merli P; Palma P; Rossi P; Di Matteo G; Locatelli F; Finocchi A; Cancrini C
    J Clin Immunol; 2022 Jan; 42(1):130-145. PubMed ID: 34664192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency.
    John T; Walter JE; Schuetz C; Chen K; Abraham RS; Bonfim C; Boyce TG; Joshi AY; Kang E; Carvalho BT; Mahajerin A; Nugent D; Puthenveetil G; Soni A; Su H; Cowan MJ; Notarangelo L; Buchbinder D
    J Clin Immunol; 2016 Oct; 36(7):725-32. PubMed ID: 27539235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches.
    Bosticardo M; Pala F; Notarangelo LD
    Eur J Immunol; 2021 May; 51(5):1028-1038. PubMed ID: 33682138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HyperIgE in hypomorphic recombination-activating gene defects.
    Castiello MC; Brandas C; Capo V; Villa A
    Curr Opin Immunol; 2023 Feb; 80():102279. PubMed ID: 36529093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGs and BUGS: An alliance for autoimmunity.
    Rigoni R; Grassi F; Villa A; Cassani B
    Gut Microbes; 2016 Nov; 7(6):503-511. PubMed ID: 27575988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations.
    Matangkasombut P; Pichavant M; Saez DE; Giliani S; Mazzolari E; Finocchi A; Villa A; Sobacchi C; Cortes P; Umetsu DT; Notarangelo LD
    Blood; 2008 Jan; 111(1):271-4. PubMed ID: 17890453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
    Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
    Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency.
    Castiello MC; Bosticardo M; Sacchetti N; Calzoni E; Fontana E; Yamazaki Y; Draghici E; Corsino C; Bortolomai I; Sereni L; Yu HH; Uva P; Palchaudhuri R; Scadden DT; Villa A; Notarangelo LD
    J Allergy Clin Immunol; 2021 Jan; 147(1):309-320.e6. PubMed ID: 32387109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens.
    Geier CB; Piller A; Linder A; Sauerwein KM; Eibl MM; Wolf HM
    PLoS One; 2015; 10(7):e0133220. PubMed ID: 26186701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.